Navigation Links
Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
Date:9/7/2011

toacidosis.

TRADJENTA has not been studied in combination with insulin.

Important Safety InformationCONTRAINDICATIONSTRADJENTA is contraindicated in patients with a history of hypersensitivity reaction to linagliptin, such as urticaria, angioedema or bronchial hyperreactivity.

WARNINGS AND PRECAUTIONSUse with Medications Known to Cause HypoglycemiaInsulin secretagogues (e.g., sulfonylurea) are known to cause hypoglycemia. Therefore, a lower dose of the insulin secretagogue may be required to reduce the risk of hypoglycemia when used in combination with TRADJENTA.

Macrovascular OutcomesThere have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with TRADJENTA or any other antidiabetic drug.

ADVERSE REACTIONSAdverse reactions reported in >/=5% of patients treated with TRADJENTA and more commonly than in patients treated with placebo included nasopharyngitis.

Hypoglycemia was more commonly reported in patients treated with the combination of TRADJENTA and sulfonylurea compared with those treated with the combination of placebo and sulfonylurea. Pancreatitis was reported more often in patients randomized to linagliptin (1 per 538 person-years versus zero in 433 person-years for comparator).

DRUG INTERACTIONSThe efficacy of TRADJENTA may be reduced when administered in combination with a strong P-glycoprotein or CYP3A4 inducer (e.g., rifampin). Therefore, use of alternative treatments is strongly recommended.

USE IN SPECIFIC POPULATIONSThere are no adequate and well-controlled studies in pregnant women. Therefore, TRADJENTA should be used during pregnancy only if clearly needed. It is not known whether linagliptin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when TRADJENTA is administered to a nursing woman. Safety and effectiveness of TRADJENTA in patients below the age of 18 have not been esta
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015  Big Cloud Analytics, Inc. ... technology, announces it is working with Intel Corporation ... the new Lockheed Martin Healthcare Technology Alliance. The ... information technology providers, medical technology companies and academic ... innovation to improve care in rapidly evolving and ...
(Date:7/30/2015)... LAGUNA HILLS, Calif. , July 30, 2015 ... developing nanoparticle drug delivery platforms, has received Orphan ... (FDA) for a second drug product that uses ... is a formulation of dactinomycin for the treatment ... bone cancer. The FDA granted NanoSmart,s Orphan Drug ...
(Date:7/30/2015)... 2015 /PRNewswire/ - Anything Technologies Media, Inc. (OTC:EXMT) has ... Garden Solutions (FIGS), www.frontiergarden.com has been ... Project Manager for a My Compassion originated medical ... located in Alaska.  The project will be funded ... Teaming Partners. The first phase of the project, ...
Breaking Medicine Technology:Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3
... WARSAW, Ind., April 12, 2011 Zimmer Holdings, Inc. (NYSE: ... quarter 2011 sales and earnings conference call will be broadcast ... 8:00 a.m. Eastern Time.  A news release detailing the quarterly ... the morning of the conference call. The ...
... April 12, 2011 /PRNewswire-Asia-FirstCall/ -- China Botanic Pharmaceutical ... or the "Company"), a developer, manufacturer and distributor ... ("TCM") in China, today announced that its wholly ... has received official approval to produce water-based mixtures. ...
Cached Medicine Technology:Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2011 Results 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 2China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures 3
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... New Energy ... District Stage Amphitheater in McMinnville, Oregon August 15th, 2015 from 9am – 12pm. ... exciting and important day for the entire community as the culmination of months of ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... organic, natural, therapeutic-grade oils from ingredients sourced all over the world, then manufactured ... considerable effort, we have developed the highest-quality oils in the industry, which we ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Radiology ... Michael Burgess, MD, (R-Tex) presenting “What’s Next for Health Care: A View From Capitol ... and founder of the Congressional Health Caucus, Rep. Burgess has a special understanding of ...
(Date:7/31/2015)... Baltimore, MD (PRWEB) , ... July 31, 2015 ... ... Lure Docs of All Types " from NBC talked about a woman’s unfortunate ... dermatology. He performed sclerotherapy on her face, which resulted in blistering, swelling, bruising, ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly Tech ... a technology expert and special reporter for NewsWatch, conducted the review and shared with ... be a very messy experience, especially when cracking eggs. Cracking an egg is easy, ...
Breaking Medicine News(10 mins):Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 2Health News:Timber Frame Raising: Granary District Stage Amphitheater Timber Frame Hand-Raising by New Energy Works Timberframers 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3Health News:Make Less Mess while Cooking with Crack’em 2
... , FRIDAY, April 20 (HealthDay News) -- Patients ... or pelvic surgery if they have open surgery rather than ... obstruction -- a blockage in the small intestines -- can ... tissue formation and is a common reason for emergency admission ...
... analyzing treatment decisions in late-stage amyotrophic lateral sclerosis (ALS) ... duration and quality of life in this progressively debilitating ... at the University of Pennsylvania found that waiting until ... not living long enough to experience the benefits. In ...
... HealthDay Reporter , FRIDAY, April 20 (HealthDay News) ... injuries with long-lasting damage in 2011 -- the highest number ... "major problem," a new report claims. The finding is ... for Catastrophic Sports Injury Research at the University of North ...
... A mysterious, difficult-to-diagnose, and potentially deadly disease that ... effectively if treatment is started within the first ... report by researchers from the Perelman School of ... analyzed 565 cases of this recently discovered paraneoplastic ...
... Could engineered human stem cells hold the key ... and Nanotechnology (IBN), the world,s first bioengineering and nanotechnology ... the innate ability to target tumor cells outside the ... on breast cancer cells, was recently published in leading ...
... , THURSDAY, April 19 (HealthDay News) -- There were 222 ... States last year, more than four times the usual annual ... had the most number of reported measles in the U.S. ... National Center for Immunization and Respiratory Disease at the U.S. ...
Cached Medicine News:Health News:Lower Risk for Bowel Obstruction With Less Invasive Surgery: Study 2Health News:ALS patients differ on treatment choices in later phases of disease 2Health News:'Catastrophic' Head Injuries to High School Football Players Rising 2Health News:'Catastrophic' Head Injuries to High School Football Players Rising 3Health News:Early treatment improves outcomes in rare, often undiagnosed form of encephalitis 2Health News:IBN discovers human neural stem cells with tumor targeting ability 2Health News:IBN discovers human neural stem cells with tumor targeting ability 3Health News:Measles Outbreaks in 2011 Were Worst in 15 Years: CDC 2
Hypervisor III Central Monitoring System...
For the critical care environment, telemetry, emergency room and other monitoring areas....
The CIC Pro Clinical Information Center brings together vital patient information from multiple monitoring devices....
... is a solution for hospitals, communicating ... signs monitoring. Waveform and numeric data ... simultaneous display of up to 32 ... trends are stored automatically. Alarms provide ...
Medicine Products: